Getinge B, SE0000202624

Getinge B stock holds steady after conference comments

Published on 09/16/2026 at 20:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Getinge B stock closed at SEK 239.60 on September 14, 2026, unchanged from the prior session. Management flagged stronger EMEA growth and weaker China demand on September 15, 2026.

Aquarell der Göteborger Uferpromenade mit Hochhäusern und Hafenkränen — Getinge AB (ISIN SE0000202624) präsentiert die Hafenstadt Göteborg als sanftes Aquarellgemälde mit Bürogebäuden und Kränen, Illustration mit AI erstellt.

Getinge B stock (ISIN SE0000202624) closed at SEK 239.60 on Nasdaq Stockholm on September 14, 2026, unchanged from the previous session. The shares traded between SEK 238.20 and SEK 239.60, and the close matched the session high.

Conference focus

According to ad hoc news, investors were digesting Getinge's appearance at the Morgan Stanley 24th Annual Global Healthcare Conference. The same report said the company pointed to stronger EMEA growth, steadier demand in the United States and continued weakness in China on September 15, 2026.

That mix matters because the stock finished at the top of its daily range while the conference takeaways highlighted both regional strength and a softer China backdrop.

Market level

Getinge B stock is trading close to its recent band after the September 14, 2026 close at SEK 239.60. The session range of SEK 238.20 to SEK 239.60 left the share 0.00 percent away from the prior close on that completed trading day.

Investor frame

The most recent source in this call also points to a market value reference of SEK 4,215.6 million for 2025 in the Inderes dataset, with a 2025 share price of SEK 148.00 and EV/EBIT of 12.6x. That puts the latest stock move in a wider valuation context rather than a clean breakout.